BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• 

  Deals

  P&G Acquires Merck KGaA’s Consumer Health Business, Pfizer Spurned Again

  Pfizer’s consumer health business has been spurned again. This time by mega-consumer goods company Proctor & Gamble. which opted today to acquire Germany-based Merck KGaA’s consumer health unit for $4.2 billion.

  April 19, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Eli Lilly and Incyte Shares Drop as FDA Raises Concerns about Arthritis Drug

  Ahead of next Monday’s U.S. Food and Drug Administration (FDA) committee review of Eli Lilly and Incyte’s baricitinib for rheumatoid arthritis, concerns over blood clots, may scuttle the drug’s chances.

  April 19, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Companies Advance Antimicrobial Treatments for Drug Resistant Bacteria

  With growing concerns about the rise of drug resistant bacteria, multiple companies are developing new forms of antimicrobials to take on serious health concerns.

  April 19, 2018

   · 

  2 min read

   · 

  Alex Keown